Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma

Background: Esophageal adenocarcinoma (EAC) remains a leading cause of cancer-related deaths worldwide and demonstrates a predominant rising incidence in Western countries. Recently, immunotherapy has dramatically changed the landscape of treatment for many advanced cancers, with the benefit in EAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Liu, Long, Jiao, Dechao, Guo, Chunguang, Wang, Libo, Li, Zhaonan, Sun, Zhenqiang, Zhao, Yanan, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166246/
https://www.ncbi.nlm.nih.gov/pubmed/34079583
http://dx.doi.org/10.3389/fgene.2021.669694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166246/
https://www.ncbi.nlm.nih.gov/pubmed/34079583
http://dx.doi.org/10.3389/fgene.2021.669694

Ejemplares similares